Knee
-
Recon
Hyalex Orthopaedics Reports Treatment of First Patients with Novel HYALEX® Knee Cartilage System
Patients Have been Successfully Enrolled in Both US and European Clinical Studies LEXINGTON, Mass., April 21, 2024 /PRNewswire/ — Hyalex Orthopaedics, a privately held…
Read More » -
Recon
Robotic knee surgery study revives debate over procedure’s benefits
As robotic assistance gains in popularity, new research has found no advantage over the conventional approach in reducing the need…
Read More » -
Recon
New Knee Research Finds Exactech Technologies Improve Patient Outcomes
GAINESVILLE, Fla., March 20, 2024 /PRNewswire/ — Exactech, a developer and producer of innovative implants, instrumentation, and smart technologies for joint replacement surgery, announced…
Read More » -
Recon
Intellijoint Surgical announces second product approval in Japan; Intellijoint KNEE
Kitchener, ON – March 2024 – Intellijoint Surgical is pleased to announce regulatory approval for Intellijoint KNEE for use in Japan. This…
Read More » -
Recon
Orthopedic Surgeon Tomas Pevny, MD, of Valley View, Is the First in the Roaring Fork Valley to Offer iovera°, a New Option to Manage Knee Pain
The iovera° Technology is a Non-Opioid Treatment Option to Help Patients Relieve the Chronic Pain of Osteoarthritis GLENWOOD SPRINGS, Colo., Feb.…
Read More » -
Biologics
Bioventus Agrees to Nationwide Contract with Aetna™ Medicare Advantage Plans for DUROLANE® for Knee Osteoarthritis
DURHAM, N.C., Dec. 06, 2023 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for…
Read More » -
Recon
American Joint Replacement Registry Releases 10th Annual Report
Report offers a snapshot of the current state of hip and knee arthroplasty practice in the United States ROSEMONT, Ill., Nov. 3,…
Read More » -
Regulatory
ZKR Orthopedics announces FDA Breakthrough Device designation for the LIFT Implant Technology
KENTFIELD, Calif., Oct. 09, 2023 (GLOBE NEWSWIRE) — ZKR Orthopedics, Inc., a clinical stage medical device company, today announced that…
Read More » -
Biologics
U.S. FDA Grants Lipogems® Second IDE Approval For A Clinical Trial On The Treatment For Knee OA
ATLANTA, Oct. 4, 2023 /PRNewswire/ — The U. S. Food and Drug Administration (FDA) has awarded Lipogems another Investigational Device Exemption (IDE) study…
Read More » -
Recon
Houston Surgeon Dr. Robert Burke Celebrates Milestone of 1,000 Technology-Assisted Total Joint Procedures
HOUSTON, Sept. 13, 2023 /PRNewswire/ — Dr. Robert Burke, orthopedic surgeon, has reached a significant milestone by successfully completing his 1,000th procedure using…
Read More » -
Top Stories
Moximed’s MISHA™ Knee System Treats First Commercial Patients in United States
Implantable shock absorber (ISA) relieves pain and improves function in people ineligible for, or unwilling to undergo, joint replacement Multiple…
Read More » -
Recon
Exactech Debuts New Primary Knee System: TriVerse™
GAINESVILLE, Fla., Spetember 5, 2023–(BUSINESS WIRE)–Exactech, a developer and producer of innovative implants, instrumentation, and smart technologies for joint replacement…
Read More » -
Sports Medicine
EpiBone to Start Clinical Trials for Knee Cartilage Grown in Lab
JERSEY CITY, N.J., July 24, 2023 /PRNewswire/ — EpiBone has received Investigational New Drug (IND) clearance from the FDA to begin testing…
Read More » -
Recon
New Exactech Knee Research Demonstrates Ability to Achieve Balanced Results with Short Learning Curve Using Newton™ Technology
GAINESVILLE, FL., April 26, 2023 –(BUSINESS WIRE)–Exactech, a developer and producer of innovative implants, instrumentation, and smart technologies for joint…
Read More » -
Regulatory
FDA Authorizes Marketing of MISHA™ Knee System for People Suffering from Knee Osteoarthritis
Implantable shock absorber (ISA) relieves pain and improves function in people ineligible for, or unwilling to undergo, joint replacement MISHA…
Read More »